Traws Pharma Inc (TRAW)

Dec 23, 2024

Traws Pharma, Inc. Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu - Marketscreener.com

Dec 23, 2024

Dec 23, 2024

Nasdaq Surges Over 100 Points, US Durable Goods Orders Decline In November - Benzinga

Dec 23, 2024

Dec 23, 2024

Traws Pharma Stock Rockets On Promising H5N1 Bird Flu Treatment Results - Benzinga

Dec 23, 2024

Dec 23, 2024

Stock market news: Direct Digital Holdings +405.45%, Reliance Global Group +214.17% among top gainers during mid day trading - Business Upturn

Dec 23, 2024

Dec 23, 2024

Stock market news: Direct Digital Holdings up by 363.64% while iLearningEngines down by 70.88% during mid day trading - Business Upturn

Dec 23, 2024

Dec 23, 2024

Traws Pharma Stock Hits 6-Month Highs On Bird Flu Treatment Breakthrough, Retail Interest Soars - Asianet Newsable

Dec 23, 2024

Dec 23, 2024

Key pre-market developments in biotech & aerospace - RagingBull

Dec 23, 2024

Dec 23, 2024

Stock market today: Traws Pharma +231.47%, Rumble +59.02% among top gainers in early trading - Business Upturn

Dec 23, 2024

Dec 23, 2024

US Stocks Mixed, Dow Tumbles 150 Points - Benzinga

Dec 23, 2024

Dec 23, 2024

Stock market today: iLearningEngines plunges by 60.44% while Reliance Global Group surged by 231.67% in early trading session - Business Upturn

Dec 23, 2024

Dec 23, 2024

Traws Pharma Shares Surge 83% on Development of Bird Flu Treatment - MarketWatch

Dec 23, 2024

Dec 23, 2024

Traws Pharma advances bird flu treatment candidate - Investing.com

Dec 23, 2024

Dec 23, 2024

Traws Pharma's Bird Flu Drug Shows Breakthrough Results in Phase 1 Trial, Achieves 23-Day Protection - StockTitan

Dec 23, 2024

Dec 23, 2024

The Most Therapeutic Kind of Me-Time - 69News WFMZ-TV

Dec 23, 2024

Dec 22, 2024

Traws Pharma announces board member departure By Investing.com - Investing.com Australia

Dec 22, 2024

Dec 22, 2024

Traws Pharma announces board member departure - Investing.com

Dec 22, 2024

Dec 20, 2024

Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says - 69News WFMZ-TV

Dec 20, 2024

Dec 20, 2024

More of America's Pets Are Overdosing on Stray Coke, Meth - 69News WFMZ-TV

Dec 20, 2024

Dec 16, 2024

Trinity Capital Commits $50M to Form Energy's Revolutionary Iron-Air Battery Manufacturing - StockTitan

Dec 16, 2024

Dec 14, 2024

Full Stock Market News from 2024-12-14 - StockTitan

Dec 14, 2024

Nov 23, 2024

Traws Pharma faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada

Nov 23, 2024

Nov 23, 2024

Traws Pharma faces Nasdaq delisting over equity shortfall - Investing.com

Nov 23, 2024

Nov 21, 2024

Onconova Therapeutics stock hits 52-week low at $4.37 - Investing.com India

Nov 21, 2024

Nov 21, 2024

Traws Pharma Faces Uncertain Future Amid Complex Onconova Merger - MSN

Nov 21, 2024

Nov 21, 2024

Onconova Therapeutics stock hits 52-week low at $4.37 By Investing.com - Investing.com Australia

Nov 21, 2024

Nov 20, 2024

Onconova Therapeutics, Inc. Announces Management Changes - Marketscreener.com

Nov 20, 2024

Nov 20, 2024

Traws Pharma Reports Q3 Financials and Updates on Clinical Advances - MSN

Nov 20, 2024

Nov 20, 2024

Traws Pharma (FRA:0T20) 3-Year EPS without NRI Growth Rate : 25.30% (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024

Nov 16, 2024

Traws Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 16, 2024

Nov 15, 2024

Traws Pharma Inc (TRAW) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 14, 2024

Traws Pharma Reports Promising Antiviral Drug Progress - TipRanks

Nov 14, 2024

Nov 14, 2024

Traws Pharma earnings missed by $8.56, revenue topped estimates - Investing.com Canada

Nov 14, 2024

Nov 14, 2024

Traws Pharma Provides Business Update and Reports Q3 2024 Financial Results - The Manila Times

Nov 14, 2024

Nov 14, 2024

Traws Pharma Reports Promising Phase 1 Data Despite Widening Q3 Losses | TRAW Stock News - StockTitan

Nov 14, 2024

Nov 08, 2024

Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update - Marketscreener.com

Nov 08, 2024

Nov 01, 2024

Traws Pharma regains Nasdaq compliance with bid price - Investing.com India

Nov 01, 2024

Nov 01, 2024

Traws Pharma regains Nasdaq compliance with bid price By Investing.com - Investing.com UK

Nov 01, 2024

Oct 10, 2024

Expert Systems Celebrates Milestone in Clinical Development of Tivoxavir Marboxil, Potential One-Time Influenza Treatment - StockTitan

Oct 10, 2024

Oct 09, 2024

Traws Pharma Inc (TRAW) Q2 2024 Earnings Call Highlights: Navigating Financial Challenges Amid ... - Yahoo Finance

Oct 09, 2024

Oct 09, 2024

Traws Pharma Reports Positive Phase 1 Results for Influenza Therapy Tivoxavir Marboxil - MyChesCo

Oct 09, 2024

Oct 08, 2024

Onconova Therapeutics stock hits 52-week low at $4.87 - Investing.com India

Oct 08, 2024

Oct 08, 2024

Traws Pharma reports positive Phase 1 flu drug results - Investing.com

Oct 08, 2024

Oct 08, 2024

Traws Pharma reports positive Phase 1 flu drug results By Investing.com - Investing.com Canada

Oct 08, 2024

Oct 08, 2024

Traws Pharma announces topline Phase 1 data for tivoxavir marboxil - TipRanks

Oct 08, 2024

Oct 08, 2024

Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil - GlobeNewswire

Oct 08, 2024

Oct 08, 2024

Traws Pharma, Inc. Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil - Marketscreener.com

Oct 08, 2024

Oct 07, 2024

Onconova Therapeutics stock hits 52-week low at $4.87 By Investing.com - Investing.com Australia

Oct 07, 2024